Skip to main content
Home
FULL MENU Close Menu
Home
Home

Erik Greb

Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.

News

Pediatric pruritus requires distinct approach to assessment and management

Author:
Erik Greb
Publish date: March 3, 2019

WASHINGTON – Issues related to quality of life differ between children and adults, and assessing itch severity in...

  • Read More

News

Eczema increases the risk of impaired mental health among children

Author:
Erik Greb
Publish date: March 3, 2019

WASHINGTON – Many children with eczema and impaired mental health may not be receiving appropriate psychological...

  • Read More

News

Depigmentation therapy may be appropriate for patients with vitiligo

Author:
Erik Greb
Publish date: March 2, 2019

WASHINGTON – The treatment is an option when repigmentation therapy fails, and it may reduce depression associated...

  • Read More

News

Deferoxamine does not improve 90-day outcomes after ICH

Author:
Erik Greb

HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.

  • Read More

News

Vaccination and antiviral treatment do not affect stroke risk following shingles

Author:
Erik Greb

HONOLULU – Preventing shingles through vaccination might be the best method for preventing shingles-associated acute...

  • Read More

News

Cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke

Author:
Erik Greb

HONOLULU – Dual therapy with cilostazol and aspirin or clopidogrel did not increase the risk of serious bleeding.

  • Read More

News

Researchers compare focused ultrasound and DBS for essential tremor

Author:
Erik Greb

LAS VEGAS – Focused ultrasound and DBS have similar efficacy in essential tremor, but their safety profiles and...

  • Read More

News

DBS may improve nonmotor symptoms in Parkinson’s disease

Author:
Erik Greb

LAS VEGAS – Stimulation of the GPI, but not of the STN, is associated with improvement in sialorrhea and urinary...

  • Read More

News

Peripheral nerve stimulation reduces hand tremor

Author:
Erik Greb

LAS VEGAS – Hand tremor and activities of daily living are improved by noninvasive neuromodulation in patients with...

  • Read More

News

Benefit of thrombectomy may be universal

Author:
Erik Greb

The proportional benefit of thrombectomy is uniform among various subgroups of patients with acute ischemic stroke.

  • Read More

News

DBS provides long-term benefits for patients with Parkinson’s disease

Author:
Erik Greb

LAS VEGAS – A large-scale collection of outcomes suggests that DBS offers sustained improvement of motor and nonmotor symptoms.

  • Read More

News

Frailty may affect the expression of dementia

Author:
Erik Greb

People with higher degrees of frailty may be more likely to have more Alzheimer’s disease pathology and clinical dementia.

  • Read More

News

DMTs, stem cell transplants both reduce disease progression in MS

Author:
Erik Greb

First- and second-line therapies reduce the risk of conversion to secondary progressive MS, and stem cell...

  • Read More

News

Population-level rate of SUDEP may have decreased

Author:
Erik Greb

NEW ORLEANS – It is unclear whether the observed decline in SUDEP incidence resulted from an intensified focus on risk reduction.

  • Read More

News

Onset of pediatric status epilepticus may have a circadian pattern

Author:
Erik Greb

NEW ORLEANS - Onset of refractory pediatric status epilepticus may peak between 10 a.m. and 11 a.m.

  • Read More

Pages

  • « first
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close